(Q41134178)

27 September 2017

Are two better than one? A novel double-mutant KIT in GIST that responds to Imatinib (English)

1 reference

27 September 2017

1 reference

9

1 reference

27 September 2017

Mara Mazzoni

6

0 references

Elena Rosa Fumagalli

Elena Fumagalli

4

0 references

Angela Greco

Angela Greco

11

0 references

Elena Tamborini

Elena Tamborini

13

0 references

Maurizio Fermeglia

Maurizio Fermeglia

7

0 references

Sabrina Pricl

Sabrina Pricl

12

0 references

Silvana Pilotti

10

Silvana Pilotti

1 reference

27 September 2017

8

Erik Laurini

1 reference

27 September 2017

3

Valentina Dal Col

1 reference

27 September 2017

1

Elena Conca

1 reference

27 September 2017

Claudia Miranda

2

1 reference

PMC publication ID

5528426

27 September 2017

Giuseppe Pelosi

5

1 reference

27 September 2017

21 March 2013

1 reference

27 September 2017

1 reference

27 September 2017

7

1 reference

27 September 2017

4

1 reference

27 September 2017

756-762

1 reference

Targeted therapy in GIST: in silico modeling for prediction of resistance

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

Imatinib treatment for gastrointestinal stromal tumour (GIST).

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

Targeted therapies: the rare cancer paradigm

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

Unlucky number 13? Differential effects of KIT exon 13 mutation in gastrointestinal stromal tumors

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

Imatinib response in two GIST patients carrying two hitherto functionally uncharacterized PDGFRA mutations: an imaging, biochemical and molecular modeling study

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

Activate and resist: L576P-KIT in GIST.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

T670X KIT mutations in gastrointestinal stromal tumors: making sense of missense

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5528426

Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients

19 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.MOLONC.2013.02.019

Diagnosis of gastrointestinal stromal tumors: A consensus approach

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23567324

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mutational spectrum and therapy response of metastasized GIST in Central Switzerland - a population-based study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23567324

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.MOLONC.2013.02.019

1 reference

27 September 2017

1 reference

PMC publication ID

5528426

27 September 2017

PubMed publication ID

23567324

1 reference

PMC publication ID

5528426